Come up with a name for your new list and we'll add to it:
SAGE Therapeutics raised a round of funding on October 18, 2011. Investors include
Third Rock Ventures.
SAGE Therapeutics is a neuroscience-focused company developing medicines to treat rare and orphan diseases of the central nervous system (CNS). SAGE's lead program, SAGE-547, is in clinical developmen…